Amneal Pharmaceuticals Inc.

AMRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$19.31

-$0.85 (-4.22%)

Sep 22, 2026, 12:45 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	72.06M	-73.88M	-48.72M	-254.79M	10.62M	91.06M
Depreciation & Amortization	223.57M	236.19M	229.4M	240.18M	233.41M	244.07M
Stock-Based Compensation	31.95M	27.77M	26.82M	31.85M	n/a	20.75M
Other Working Capital	-18.23M	53.48M	47.64M	11.95M	-24.34M	35.37M
Other Non-Cash Items	216.93M	109.08M	185.26M	107.81M	131.38M	84.75M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-204.52M	-4.07M	-47.19M	-59.95M	-133.59M	-61.63M
Operating Cash Flow	339.99M	295.1M	345.58M	65.1M	241.82M	379M
Capital Expenditures	-70.06M	-74.99M	-69.19M	-90.6M	-47.73M	-61.84M
Cash Acquisitions	n/a	11.99M	n/a	-84.71M	-141.54M	-251.36M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-42.2M	-14.65M	-22.39M	-40.8M	-3.21M	-4.35M
Investing Cash Flow	-112.26M	-63M	-69.19M	-174.31M	-194.18M	-317.55M
Debt Repayment	26.27M	-185.12M	22.65M	-38.27M	-79.18M	142.99M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-863K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-59.76M	-26.67M	-235.23M	-68.35M	-59.8M	-10.32M
Financial Cash Flow	-31.53M	-211.79M	-212.57M	-106.62M	-138.12M	131.81M
Net Cash Flow	194.52M	19.31M	63.88M	-221.51M	-90.38M	194.3M
Free Cash Flow	269.93M	220.11M	276.39M	-25.5M	194.09M	317.16M
Adj. Free Cash Flow	237.98M	192.34M	249.57M	-57.34M	194.09M	296.41M
Maintenance CapEx	-13.24M	n/a	-12.99M	-50.93M	-12.14M	n/a
Growth CapEx	-56.83M	-74.99M	-56.2M	-39.67M	-35.58M	-61.84M
Owner Earnings	326.76M	295.1M	332.59M	14.17M	229.68M	379M